European Pharmaceutical Review
OCTOBER 18, 2022
billion by 2030, according to a market report. However, during the second half, the surge in demand for vaccines to fight the coronavirus enhanced the industry’s need for raw materials and product intermediates of API molecules. billion by 2030 appeared first on European Pharmaceutical Review. billion in 2022 to $14.65
Express Pharma
NOVEMBER 28, 2023
It is crucial to find a delicate balance in antibiotic dosages, acknowledging that overuse contributes to resistance. Dr Ranga Reddy, President, Infection Control Academy of India said, “AMR poses a threat to various aspects of life, undermining the 2030 Sustainable Development Goals, especially in regions with inadequate sanitation.
European Pharmaceutical Review
SEPTEMBER 7, 2022
The second most commonly used pharmaceutical dosage form, capsules, are anticipated to be a $5.2 billion market by 2030, growing from a 2020 value of around $2.4 Compared with other oral solid dosage forms (OSDs), capsules also offer the easiest method to achieve fixed-dose combinations (FDCs) of incompatible drug substances.
Expert insights. Personalized for you.
90 
Let's personalize your content